TCTC Holdings’s Medtronic MDT Stock Holding History

TCTC Holdings’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.29M	Buy	42,088 +2,785	+7%	+$225K	0.09%	101
2026 Q1	$3.41M	Sell	39,303 -690	-2%	-$66.1K	0.1%	98
2025 Q4	$3.84M	Sell	39,993 -90	-0.2%	-$8.74K	0.11%	95
2025 Q3	$3.82M	Buy	40,083 +4,876	+14%	+$448K	0.11%	96
2025 Q2	$3.07M	Sell	35,207 -4,225	-11%	-$358K	0.1%	100
2025 Q1	$3.54M	Sell	39,432 -286	-0.7%	-$25.6K	0.12%	94
2024 Q4	$3.17M	Buy	39,718 +1,301	+3%	+$113K	0.11%	95
2024 Q3	$3.46M	Buy	38,417 +650	+2%	+$54.7K	0.12%	93
2024 Q2	$2.97M	Sell	37,767 -1,172	-3%	-$96.1K	0.1%	92
2024 Q1	$3.39M	Buy	38,939 +22	+0.1%	+$1.88K	0.11%	90
2023 Q4	$3.21M	Buy	38,917 +4,320	+12%	+$329K	0.12%	90
2023 Q3	$2.71M	Sell	34,597 -8,209	-19%	-$687K	0.1%	89
2023 Q2	$3.77M	Sell	42,806 -2,374	-5%	-$204K	0.15%	86
2023 Q1	$3.64M	Buy	45,180 +73	+0.2%	+$5.95K	0.15%	84
2022 Q4	$3.51M	Sell	45,107 -17,259	-28%	-$1.4M	0.14%	83
2022 Q3	$5.04M	Sell	62,366 -2,358	-4%	-$212K	0.22%	75
2022 Q2	$5.81M	Buy	64,724 +68	+0.1%	+$6.89K	0.26%	74
2022 Q1	$7.17M	Buy	64,656 +2,647	+4%	+$280K	0.29%	72
2021 Q4	$6.42M	Sell	62,009 -1,650	-3%	-$191K	0.27%	73
2021 Q3	$7.98M	Sell	63,659 -2,280	-3%	-$295K	0.37%	61
2021 Q2	$8.19M	Buy	65,939 +228	+0.3%	+$28.6K	0.38%	62
2021 Q1	$7.76M	Buy	65,711 +1,530	+2%	+$179K	0.37%	62
2020 Q4	$7.52M	Buy	64,181 +1,374	+2%	+$151K	0.4%	59
2020 Q3	$6.53M	Buy	62,807 +4,785	+8%	+$481K	0.4%	59
2020 Q2	$5.32M	Buy	58,022 +323	+0.6%	+$31K	0.32%	63
2020 Q1	$5.2M	Buy	57,699 +1,569	+3%	+$167K	0.39%	54
2019 Q4	$6.37M	Buy	56,130 +1,071	+2%	+$118K	0.33%	57
2019 Q3	$5.98M	Sell	55,059 -965	-2%	-$101K	0.31%	57
2019 Q2	$5.46M	Buy	56,024 +2,885	+5%	+$263K	0.3%	61
2019 Q1	$4.84M	Buy	53,139 +390	+0.7%	+$34.9K	0.26%	64
2018 Q4	$4.8M	Buy	52,749 +512	+1%	+$47.8K	0.27%	61
2018 Q3	$5.14M	Sell	52,237 -9	-0%	-$832	0.24%	62
2018 Q2	$4.47M	Sell	52,246 -300	-0.6%	-$25.1K	0.22%	66
2018 Q1	$4.21M	Buy	52,546 +16,445	+46%	+$1.36M	0.22%	64
2017 Q4	$2.92M	Buy	36,101 +2,466	+7%	+$197K	0.15%	70
2017 Q3	$2.62M	Buy	33,635 +6,291	+23%	+$522K	0.16%	68
2017 Q2	$2.43M	Hold	27,344	–	–	0.17%	69
2017 Q1	$2.2M	Sell	27,344 -600	-2%	-$46.9K	0.14%	83
2016 Q4	$1.99M	Sell	27,944 -40	-0.1%	-$3.14K	0.12%	86
2016 Q3	$2.42M	Hold	27,984	–	–	0.18%	74
2016 Q2	$2.43M	Sell	27,984 -200	-0.7%	-$16.2K	0.16%	82
2016 Q1	$2.11M	Sell	28,184 -2,720	-9%	-$205K	0.13%	86
2015 Q4	$2.38M	Sell	30,904 -2,375	-7%	-$179K	0.14%	78
2015 Q3	$2.23M	Sell	33,279 -1,777	-5%	-$131K	0.13%	83
2015 Q2	$2.6M	Sell	35,056 -2,000	-5%	-$153K	0.15%	80
2015 Q1	$2.89M	Sell	37,056 -4,660	-11%	-$353K	0.17%	77
2014 Q4	$3.01M	Sell	41,716 -1,267	-3%	-$88K	0.18%	77
2014 Q3	$2.66M	Sell	42,983 -1,825	-4%	-$116K	0.15%	78
2014 Q2	$2.86M	Sell	44,808 -200	-0.4%	-$12.2K	0.18%	65
2014 Q1	$2.77M	Sell	45,008 -3,850	-8%	-$224K	0.16%	78
2013 Q4	$2.8M	Sell	48,858 -1,600	-3%	-$90.7K	0.16%	76
2013 Q3	$2.69M	Buy	50,458 +300	+0.6%	+$16.1K	0.17%	74
2013 Q2	$2.58M	Buy	+50,158	New	+$2.48M	0.17%	73

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

TCTC Holdings's MDT Position: Q2 2026 in Review

TCTC Holdings increased its Medtronic (MDT) stake by 7.1% in Q2 2026, buying an estimated $225K and bringing the position to 42,088 shares worth $3.29M. The position accounts for 0.09% of the portfolio, ranked #101.

TCTC Holdings first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.19M in Q2 2021. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

TCTC Holdings held 42,088 shares of Medtronic worth $3.29M as of Q2 2026.
TCTC Holdings bought 2,785 Medtronic shares in Q2 2026, an estimated $225K.
Medtronic made up 0.09% of TCTC Holdings's portfolio in Q2 2026, its #101 holding.
TCTC Holdings first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
TCTC Holdings's Medtronic position peaked at $8.19M in Q2 2021.
2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on TCTC Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.